Topiramate Treatment of Alcohol Use Disorder in Clinical Practice.


Journal

Journal of addiction medicine
ISSN: 1935-3227
Titre abrégé: J Addict Med
Pays: Netherlands
ID NLM: 101306759

Informations de publication

Date de publication:
Historique:
pubmed: 11 8 2018
medline: 13 3 2020
entrez: 11 8 2018
Statut: ppublish

Résumé

: Topiramate is an anticonvulsant medication with increasingly strong evidence, supporting its use for treating alcohol use disorder (AUD) based on clinical trials. These clinical cases summarize the initiation and titration of topiramate in AUD treatment. The core issues of patient selection, consideration of comorbid psychiatric and medical conditions, side-effect profile, safety and effectiveness are reviewed. Addiction physicians should take a leading role in using topiramate to treat AUDs, working with patients to balance the benefits of topiramate with the risk.

Identifiants

pubmed: 30096078
doi: 10.1097/ADM.0000000000000444
doi:

Substances chimiques

Central Nervous System Agents 0
Topiramate 0H73WJJ391

Types de publication

Case Reports Clinical Conference Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-27

Auteurs

Hussam Jefee-Bahloul (H)

University of Massachusetts Medical School, Worcester, MA (HJ-B); Massachusetts General Hospital, Boston, MA (LJ); and Yale University School of Medicine, New Haven, CT (HJ-B, AJA).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH